GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 2801 - 2825 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▼
IgM Patient 3 11 mild
G38488WF
83
IgM Patient 3 4 mild
G38488WF
83
IgM Patient 3 4 mild
G94576MN
83
IgG Patient 4 12 mild
G86156UJ
83
IgG Patient 2 15 mild
G10133VD
82
IgG Patient 2 24 mild
G65889KE
82
IgG Patient 2 3 mild
G73271MD
82
IgM Patient 2 24 mild
G92823JK
82
IgM Patient 2 3 mild
G82204SH
82
IgM Patient 2 3 mild
G90562PB
82
IgM Patient 3 -180 mild
G58547FH
82
IgG Patient 3 11 mild
G82779CI
82
IgM Patient 4 12 mild
G93351GM
82
IgM Patient 2 15 mild
G00068MO
81
IgG Patient 3 -180 mild
G00066MO
81
IgG Patient 3 -180 mild
G52880ZN
81
IgM Patient 3 -180 mild
G24432YB
81
IgG Patient 3 11 mild
G94576MN
81
IgM Patient 3 11 mild
G21320TF
81
IgM Patient 3 4 mild
G00054MO
81
IgM Patient 1 22 moderate
G26295XE
80
IgM Patient 1 22 moderate
G82779CI
80
IgG Patient 2 15 mild
G47548GA
80
IgM Patient 2 15 mild
G37036SF
80
IgG Patient 2 3 mild
G36191CD
80

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024